Format

Send to

Choose Destination
Pharmacogenomics. 2006 Mar;7(2):255-9.

Systems pharmacogenomics in yeast.

Author information

1
Washington University School of Medicine, Department of Medicine, Division of Oncology, Computational Biology Program, St Louis, Missouri 63110, USA. pcahan@wustl.edu

Abstract

Evaluation of: Lee W, St Onge RP, Proctor M et al.: Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet. 1(2), e24 (2005). Despite intense study, the mechanistic and therapeutic differences in cellular responses to DNA-damaging agents are not fully understood. In order to expand knowledge of DNA damage, the authors of this study assayed the effects of 12 anticancer agents on the complete pool of approximately 4700 homozygous deletion strains of Saccharomyces cerevisiae. The screens identified genes in well-characterized DNA, in addition to genes whose role in DNA-damage-response pathways had not previously been established.

PMID:
16515406
DOI:
10.2217/14622416.7.2.255
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center